pamidronate
In December 2024, P&T designated pamidronate as inpatient non-formulary and zoledronic acid on formulary. Implementation of this formulary change is pending.
In December 2024, P&T designated pamidronate as inpatient non-formulary and zoledronic acid on formulary. Implementation of this formulary change is pending.